IRLSX
Price
$77.42
Change
+$0.26 (+0.34%)
Updated
Jul 16 closing price
Net Assets
1.55B
RGACX
Price
$80.30
Change
+$0.33 (+0.41%)
Updated
Jul 16 closing price
Net Assets
322.72B
Interact to see
Advertisement

IRLSX vs RGACX

Header iconIRLSX vs RGACX Comparison
Open Charts IRLSX vs RGACXBanner chart's image
Voya Russell Large Cap Growth Idx Port S
Price$77.42
Change+$0.26 (+0.34%)
VolumeN/A
Net Assets1.55B
American Funds Growth Fund of Amer R3
Price$80.30
Change+$0.33 (+0.41%)
VolumeN/A
Net Assets322.72B
IRLSX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IRLSX vs. RGACX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRLSX is a StrongBuy and RGACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 323B vs. IRLSX (1.55B). IRLSX pays higher dividends than RGACX: IRLSX (0.08) vs RGACX (0.07). IRLSX was incepted earlier than RGACX: IRLSX (16 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than IRLSX (0.80). IRLSX is a more actively managed with annual turnover of: 29.00 vs. RGACX (25.00). IRLSX has a lower initial minimum investment than RGACX: IRLSX (0) vs RGACX (250). RGACX annual gain was more profitable for investors over the last year : 8.69 vs. IRLSX (0.60). IRLSX return over 5 years is better than : 66.83 vs. RGACX (43.38).
IRLSXRGACXIRLSX / RGACX
Total Expense Ratio0.680.9472%
Annual Report Gross Expense Ratio0.800.9485%
Fund Existence16 years23 years-
Gain YTD-5.12311.543-44%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.55B323B0%
Annual Yield % from dividends0.080.07110%
Returns for 1 year0.608.697%
Returns for 3 years58.2457.35102%
Returns for 5 years66.8343.38154%
Returns for 10 years210.7877.95270%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMMT28.273.91
+16.05%
Summit Therapeutics
AC37.680.38
+1.02%
Associated Capital Group
ELMD18.420.18
+0.99%
Electromed
MTVA0.670.01
+0.93%
MetaVia Inc
CRI30.20-0.56
-1.82%
Carter's